GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (OSL:CRNA) » Definitions » Additional Paid-In Capital

Circio Holding ASA (OSL:CRNA) Additional Paid-In Capital : kr7.23 Mil(As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Circio Holding ASA Additional Paid-In Capital?


Circio Holding ASA's quarterly additional paid-in capital declined from Jun. 2023 (kr6.15 Mil) to Dec. 2023 (kr0.00 Mil) but then increased from Dec. 2023 (kr0.00 Mil) to Jun. 2024 (kr7.23 Mil).

Circio Holding ASA Additional Paid-In Capital Historical Data

The historical data trend for Circio Holding ASA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Additional Paid-In Capital Chart

Circio Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 886.90 1,046.48 - - -

Circio Holding ASA Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - 6.15 - 7.23

Circio Holding ASA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Circio Holding ASA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Circio Holding ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (OSL:CRNA) » Definitions » Additional Paid-In Capital
Comparable Companies
OSL:SOFTX OSL:ABTEC OSL:PCIB OSL:ABS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN
Traded in Other Exchanges
TA50:Germany
Address
Saint Olavs plass, Pb. 6887, Oslo, NOR, 0130
Website
https://www.circio.com
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.

Circio Holding ASA Headlines

No Headlines